President Biden's top medical adviser said children in high school—between the ages of 12 to 17 or 18—will be vaccinated in the fall. First school pupils will be vaccinated early next year.
Black and brown Los Angeles, California, residents—who are most likely to die from the coronavirus—are being vaccinated at low rates despite efforts to reach them.
A poll released by The Associated Press-NORC Center for Public Affairs Research on February 10 found that hesitancy around the vaccine was more prominent among Black Americans compared with other ethnicities.
Speculation and Google searches increased after a conspiracy theory website claimed India had banned the Pfizer-BioNTech COVID-19 vaccine due to safety concerns.
Thrombocytopenia can be triggered as an immune response to medication or infection, but a link between the condition and COVID-19 has not been proven.
The New York congresswoman said she had been afraid that she might not be able to "run or fight as effectively as I normally would" as rioters tried to breach her office at the U.S. Capitol.
Pfizer, Johnson & Johnson and other drug companies are working to block votes on shareholder resolutions that would force the companies to disclose how government funding affects their drug pricing.
Johnson & Johnson say their vaccine is 66 percent effective overall in preventing moderate to severe COVID-19.
The coronavirus could mutate into a variant that renders current vaccines weakened or obsolete—before the rollout reaches the 150 million or so people needed to achieve herd immunity. Is it already too late?
The makers of both of the only COVID-19 vaccines approved for use in the U.S. have announced that they are developing booster shots to improve protection against emerging strains of virus.
Moderna is developing a version that could be used as a booster shot against the South Africa variant of the virus, as its vaccine was slightly less effective against it.
A new Siena College poll also found that a majority of New Yorkers believe the worst of the coronavirus pandemic is still to come.
The study took place in Israel, which is currently leading the world in terms of vaccinating its population.
Years of emergencies have taught Israel life can change in an instance—and despite the chaos of everyday life, citizens and state can come together with remarkable efficiency in a time of need.
Maximum protection from the Pfizer-BioNtech vaccine—as well as long-lasting immunity—is only reached seven or more days after the second dose.
Some 57 vials of the Moderna COVID-19 vaccine were left out overnight, leading to 500 vaccine doses being thrown away.
Of the more than 2 million people who have COVID vaccines, around a dozen have experienced allergic reactions.
Production delays may have also severely undercut the actual number of manufactured doses to about half of Trump's pledged amount.
Prince Mohammed bin Salman's broadcasted vaccination came after several other political leaders were given their first jabs on television.
But such incident are rare and experts say the benefits of getting the vaccine far outweigh the risks.
Over 30,000 people in the city have had the Pfizer vaccine without experiencing a reaction, according to officials.
The U.S. has purchased enough doses of coronavirus vaccines to innoculate 200 million people by summer, just shy of the 70 percent needed to achieve herd immunity.
"I'm going to continue to fight for our most vulnerable communities," the progressive lawmaker said.
The director of the National Institute of Allergy and Infectious Diseases had the shot after Health and Human Services Secretary Alex Azar.
The GOP senator from Iowa received the COVID-19 vaccine on Sunday despite saying earlier she was "so skeptical" of the coronavirus mortality rate and suggesting health-care workers were faking the number of COVID deaths.
A total of around 51 million people will be eligible for the vaccine in the next round of inoculations, including 30 million frontline essential workers.
"It was a planning error," said Gustave Perna on Saturday, after states learned they'll receive fewer doses of Pfizer's COVID-19 vaccine next week than they had been anticipating.
The FDA has approved a second COVID-19 vaccine, as health workers describe their optimism that the shots offer an end to the pandemic.
More than 5.9 million doses of Moderna's vaccine are expected to be delivered to governors for statewide allocation.